Patents by Inventor Jeffrey M. Goldberg
Jeffrey M. Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180353536Abstract: A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.Type: ApplicationFiled: January 5, 2018Publication date: December 13, 2018Inventors: Hitesh R. Bhagat, Jeffrey M. Goldberg
-
Patent number: 9895315Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: GrantFiled: December 14, 2016Date of Patent: February 20, 2018Assignee: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Publication number: 20170326172Abstract: A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.Type: ApplicationFiled: January 26, 2017Publication date: November 16, 2017Applicant: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg
-
Publication number: 20170246114Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: ApplicationFiled: December 14, 2016Publication date: August 31, 2017Applicant: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Patent number: 9585911Abstract: A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.Type: GrantFiled: June 25, 2015Date of Patent: March 7, 2017Assignee: GENZYME CORPORATIONInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg
-
Patent number: 9555056Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: GrantFiled: July 9, 2014Date of Patent: January 31, 2017Assignee: GENZYME CORPORATIONInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Publication number: 20160113961Abstract: A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.Type: ApplicationFiled: June 25, 2015Publication date: April 28, 2016Inventors: Hitesh R. Bhagat, Jeffrey M. Goldberg
-
Patent number: 9095509Abstract: A powder formulation comprises a pharmaceutically acceptable anionic stabilizer and an aliphatic amine polymer or a pharmaceutically acceptable salt thereof mixed with the anionic stabilizer. The powder formulation is conveniently packaged in a container, such as a sachet. A method of treating a subject with hyperphosphotemia with the powder formulation is also disclosed.Type: GrantFiled: September 12, 2006Date of Patent: August 4, 2015Assignee: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg
-
Publication number: 20150104510Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: ApplicationFiled: July 9, 2014Publication date: April 16, 2015Inventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Patent number: 8808738Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: GrantFiled: July 14, 2011Date of Patent: August 19, 2014Assignee: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Publication number: 20130121679Abstract: A camera holder and activation device enables a user to take pictures from vantage points spaced from the user's head. A frame defines a camera support position and an attachment device removably mounts the camera to the frame at the camera support position. An extension member such as a monopole is connected to the frame, whereby the frame may be so spaced from a user that the user cannot directly view a contemplated picture via a picture-framing element of the camera. A shifter member is movably mounted to the frame and is provided with a projection extending towards the camera support position so that motion of the shifter member brings the projection into contact with a shutter button of the camera mounted to the frame at the support position.Type: ApplicationFiled: January 7, 2013Publication date: May 16, 2013Inventors: Jeffrey M. Goldberg, Murray G. Goldberg
-
Patent number: 8348527Abstract: A camera holder and activation device enables a user to take pictures from vantage points spaced from the user's head. A frame defines a camera support position and an attachment device removably mounts the camera to the frame at the camera support position. An extension member such as a monopole is connected to the frame, whereby the frame may be so spaced from a user that the user cannot directly view a contemplated picture via a picture-framing element of the camera. A shifter member is movably mounted to the frame and is provided with a projection extending towards the camera support position so that motion of the shifter member brings the projection into contact with a shutter button of the camera mounted to the frame at the support position.Type: GrantFiled: October 14, 2010Date of Patent: January 8, 2013Inventors: Jeffrey M. Goldberg, Murray G. Goldberg
-
Publication number: 20120121704Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: ApplicationFiled: July 14, 2011Publication date: May 17, 2012Applicant: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Patent number: 7985418Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: GrantFiled: October 27, 2005Date of Patent: July 26, 2011Assignee: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Publication number: 20110091195Abstract: A camera holder and activation device enables a user to take pictures from vantage points spaced from the user's head. A frame defines a camera support position and an attachment device removably mounts the camera to the frame at the camera support position. An extension member such as a monopole is connected to the frame, whereby the frame may be so spaced from a user that the user cannot directly view a contemplated picture via a picture-framing element of the camera. A shifter member is movably mounted to the frame and is provided with a projection extending towards the camera support position so that motion of the shifter member brings the projection into contact with a shutter button of the camera mounted to the frame at the support position.Type: ApplicationFiled: October 14, 2010Publication date: April 21, 2011Inventors: Jeffrey M. Goldberg, Murray G. Goldberg